This medication is given by IV infusion.
Lemtrada™ is a humanized monoclonal antibody directed at CD52 (a protein on the surface
of immune cells).
Lemtrada is approved by the FDA for the treatment of patients with relapsing forms of
MS. Because of Lemtrada’s safety profile, the FDA recommends that this medication
generally be reserved for people who have had an inadequate response to two or more MS
to read the Lemtrada Prescribing Information for healthcare professionals.
to read the Lemtrada Medication Guide for patients.
Call Genzyme at 1- 855-MSOne2One (1-855-676-6326)
Financial Assistance Program
Usage in MS: Disease-Modifying Agent
MS One to One
1- 855-MSOne2One (1-855-676-6326)
National Infusion Center Association - non-profit patient advocacy organization which offers an online Infusion Center Finder to locate centers throughout the U.S.